Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16559 |
Poloxime
|
PLK | Cell Cycle/Checkpoint |
Poloxime is a hydrolysis product of poloxin and is a non-ATP-competitive Plk1 inhibitor. It also has moderate Plk1 inhibitory activity. |